Home     Site Map     Legal   

  Overview

MBC Pharma, Inc. is a pharmaceutical company discovering and developing novel medicines for the treatment of oncology, bone and infectious diseases. MBC Pharma's patented technologies improve upon the benefit of known drugs by adding tissue targeting and increased cancer cell specificity and uptake.

MBC Pharma's mission is to create value through discovery and development novel therapeutics to treat important oncological, bone and infectious diseases, using the Company's platform technologies.

Currently MBC R&D programs are based on two core proprietary discovery platforms

  • Bone-targeted anti-cancer compounds - cancer-induced bone disease, osteosarcoma, multiple myeloma
    • Lead compound, MBC-11 completed IND-enabling studies and has recently been licensed to Osteros Biomedica Ltd., part of the well-known Russian holding company Maxwell Biotech Group. Clinical studies will begin in 2013.
    • Novel platform expanding compounds are under pre-clinical development.

  • Vitamin-based pro-drugs - oncology and viral diseases indications
    • Discovery research with novel compounds for the treatment of pancreatic cancer is ongoing.


MBC Pharma, Inc.   12635 E.Montview Blvd., Suite 100  Aurora, CO 80045
Phone: 720-859-4041  Fax: 303-484-3532
Email: information@mbcpharma.com